SIP
ESPR

Stoneridge Investment Partners’s Esperion Therapeutics ESPR Stock Holding History

Stoneridge Investment Partners’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-117,958
Closed -$195K – 151
2024
Q3 		$195K Hold
117,958
– – 0.07% 94
2024
Q2 		$262K Buy
117,958
+24,557
+26% +$57.8K 0.1% 97
2024
Q1 		$250K Buy
93,401
+64,145
+219% +$156K 0.1% 95
2023
Q4 		$87K Hold
29,256
– – 0.04% 88
2023
Q3 		$29K Hold
29,256
– – 0.01% 99
2023
Q2 		$41K Buy
+29,256
New +$40.9K 0.02% 106

Other funds holding ESPR

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $2.17B AUM 169.27% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return